Pablo Sanchez-Salcedo
- Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelBy Pablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, Victor Pinto-Plata, Juan P. de-Torres, Claudia Cote, Carlos Cabrera, Jorge Zagaceta, Roberto Rodriguez-Roisin, Javier J. Zulueta, Jose Maria Marin and Bartolome CelliPablo Sanchez-Salcedo1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainMiguel Divo2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USACiro Casanova3Pulmonary Dept, Hospital Universitario La Candelaria, Tenerife, SpainVictor Pinto-Plata2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USAJuan P. de-Torres1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainClaudia Cote4Bay Pines VA Health Care System, St Petersburg, FL, USACarlos Cabrera5Pulmonary Dept, Hospital Universitario Dr Negrín, Las Palmas de Gran Canaria, SpainJorge Zagaceta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainRoberto Rodriguez-Roisin6Pulmonary Dept, Hospital Clínic-IDIBAPS-CIBERES, Barcelona, SpainJavier J. Zulueta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainJose Maria Marin7Pulmonary Dept, Hospital Miguel Servet, Zaragoza, SpainBartolome Celli2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USA
- Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelBy Pablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, Victor Pinto-Plata, Juan P. de-Torres, Claudia Cote, Carlos Cabrera, Jorge Zagaceta, Roberto Rodriguez-Roisin, Javier J. Zulueta, Jose Maria Marin and Bartolome CelliArticle | Published in 2014 in European Respiratory JournalPablo Sanchez-Salcedo1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainMiguel Divo2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USACiro Casanova3Pulmonary Dept, Hospital Universitario La Candelaria, Tenerife, SpainVictor Pinto-Plata2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USAJuan P. de-Torres1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainClaudia Cote4Bay Pines VA Health Care System, St Petersburg, FL, USACarlos Cabrera5Pulmonary Dept, Hospital Universitario Dr Negrín, Las Palmas de Gran Canaria, SpainJorge Zagaceta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainRoberto Rodriguez-Roisin6Pulmonary Dept, Hospital Clinic, Barcelona, SpainJavier J. Zulueta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainJose Maria Marin7Pulmonary Dept, Hospital Miguel Servet, Zaragoza, SpainBartolome Celli2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USA
- Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelBy Pablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, Victor Pinto-Plata, Juan P. de-Torres, Claudia Cote, Carlos Cabrera, Jorge Zagaceta, Roberto Rodriguez-Roisin, Javier J. Zulueta, Jose Maria Marin and Bartolome CelliArticle | Published in 2014 in European Respiratory JournalPablo Sanchez-Salcedo1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainMiguel Divo2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USACiro Casanova3Pulmonary Dept, Hospital Universitario La Candelaria, Tenerife, SpainVictor Pinto-Plata2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USAJuan P. de-Torres1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainClaudia Cote4Bay Pines VA Health Care System, St Petersburg, FL, USACarlos Cabrera5Pulmonary Dept, Hospital Universitario Dr Negrín, Las Palmas de Gran Canaria, SpainJorge Zagaceta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainRoberto Rodriguez-Roisin6Pulmonary Dept, Hospital Clinic, Barcelona, SpainJavier J. Zulueta1Pulmonary Dept, Clinica Universidad de Navarra, Pamplona, SpainJose Maria Marin7Pulmonary Dept, Hospital Miguel Servet, Zaragoza, SpainBartolome Celli2Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, MA, USA
- The BODE index predicts mortality better than 2007 GOLD and GOLD ABCDBy Juan Bertó Botella, Victor Pinto-Plata, Miguel Divo, José María Marín, Bartolome Celli, Ciro Casanova, Carlos Cabrera, Jorge Zagaceta, Pablo Sánchez-Salcedo, Esmeralda López-Zalduendo, Javier Zulueta, Juan Pablo Juan Pablo and Bartolome CelliJuan Bertó Botella1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainVictor Pinto-Plata2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Miguel Divo2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,José María Marín2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Bartolome Celli2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Ciro Casanova2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Carlos Cabrera2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Jorge Zagaceta2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,Pablo Sánchez-Salcedo1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainEsmeralda López-Zalduendo1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainJavier Zulueta1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainJuan Pablo Juan Pablo1Pulmonology, Clínica Universidad Navarra, Pamplona, Navarra, SpainBartolome Celli2Pulmonology and Critical Care, Brigham and Women´s Hospital, Boston, MA,
- Chronic obstructive pulmonary disease comorbidities networkBy Miguel J. Divo, Ciro Casanova, Jose M. Marin, Victor M. Pinto-Plata, Juan P. de-Torres, Javier J. Zulueta, Carlos Cabrera, Jorge Zagaceta, Pablo Sanchez-Salcedo, Juan Berto, Rebeca Baz Davila, Ana B. Alcaide, Claudia Cote and Bartolome R. CelliArticle | Published in 2015 in European Respiratory JournalMiguel J. Divo1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USACiro Casanova2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainJose M. Marin3Respiratory Service, Hospital Universitario Miguel Servet, Zaragoza, SpainVictor M. Pinto-Plata1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USAJuan P. de-Torres4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJavier J. Zulueta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainCarlos Cabrera5Pulmonary Department, Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canarias, SpainJorge Zagaceta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainPablo Sanchez-Salcedo4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJuan Berto4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainRebeca Baz Davila2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainAna B. Alcaide4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainClaudia Cote6Division of Pulmonary and Critical Care Medicine, The Bay Pines Veterans Affairs Healthcare System, University of South Florida, Tampa, FL, USABartolome R. Celli1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- COPD comorbidities networkBy Miguel J. Divo, Ciro Casanova, Jose M. Marin, Victor M. Pinto-Plata, Juan P. de-Torres, Javier J. Zulueta, Carlos Cabrera, Jorge Zagaceta, Pablo Sanchez-Salcedo, Juan Berto, Rebeca Baz Davila, Ana B. Alcaide, Claudia Cote and Bartolome R. CelliMiguel J. Divo1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USACiro Casanova2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainJose M. Marin3Respiratory Service, Hospital Universitario Miguel Servet, Zaragoza, SpainVictor M. Pinto-Plata1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USAJuan P. de-Torres4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJavier J. Zulueta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainCarlos Cabrera5Pulmonary Department, Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canarias, SpainJorge Zagaceta4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainPablo Sanchez-Salcedo4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainJuan Berto4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainRebeca Baz Davila2Pulmonary Department, Hospital Universitario La Candelaria, Universidad de La Laguna, Santa Cruz de Tenerife, SpainAna B. Alcaide4Department of Pulmonology, University Clinic of Navarra, Pamplona, SpainClaudia Cote6Division of Pulmonary and Critical Care Medicine, The Bay Pines Veterans Affairs Healthcare System, University of South Florida, Tampa, FL, USABartolome R. Celli1Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- Exploring the neutrophil/lymphocyte and platelet/lymphocyte ratios as biomarkers for lung cancer developmentBy Pablo Sanchez-Salcedo, Jessica Gonzalez, Diego Martinez-Urbistondo, Juan Berto, Pilar Rivera, Esmeralda Lopez-Zalduendo, Ana Belen Alcaide, Arantzazu Campo, Juan Pablo De Torres and Javier ZuluetaPablo Sanchez-Salcedo1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainJessica Gonzalez1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainDiego Martinez-Urbistondo2Internal Medicine Department, Clinica Universidad de Navarra, Pamplona, SpainJuan Berto1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainPilar Rivera1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainEsmeralda Lopez-Zalduendo1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainAna Belen Alcaide1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainArantzazu Campo1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainJuan Pablo De Torres1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, SpainJavier Zulueta1Pulmonary Department, Clinica Universidad de Navarra, Pamplona, Spain
- Lung Diseases and Cancer
Edited by Miguel Ángel Martínez-García, Mina Gaga and Kwun M. FongBook | Published in 2022DOI: 10.1183/2312508X.erm9822ISBN (electronic): 978-1-84984-155-9Miguel Ángel Martínez-GarcíaMina Gaga
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
